This is a report on the largest series on the use of rFVIIa in treating patients suffering from uncontrolled bleeding as a result of trauma in spite of surgical treatment and blood transfusion. There were 19 patients who received 1-3 doses of rFVIIa, and bleeding was controlled in 15 of them. Transfusion requirement was reduced, and shortening in PT and APTT was noticed. In spite of high risk of systemic coagulopathy in this group, treatment with rFVIIa was not complicated by DIC, but one patient suffered with clinical DVT. The review concludes that these encouraging anecdotal reports require controlled studies to prove the role of rFVIIa in the management of severe bleeding secondary to trauma.
– Maadh Aldouri
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Follow us
Subscribe to our newsletter
- Tutorials
- Resources
- Guides
- Examples
- Docs
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
-
Always ActiveNecessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Name Domain Purpose Expiry Type wpl_user_preference nataonline.com WP GDPR Cookie Consent Preferences 1 year HTTP
-
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
-
Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Name Domain Purpose Expiry Type _ga nataonline.com Google Universal Analytics long-time unique user tracking identifier. 2 years HTTP
-
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
-
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Name Domain Purpose Expiry Type _gcl_au nataonline.com --- 3 months --- test_cookie doubleclick.net A generic test cookie set by a wide range of web platforms. Session HTTP _ga_1MSM2DBRCN nataonline.com --- 2 years ---
Cookie Settings